This page shows NOVONIX LIMITED (NVX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
NOVONIX LIMITED's revenue declined 4.1% year-over-year, from $5.9M to $5.6M. This contraction results in a growth score of 27/100.
NOVONIX LIMITED carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
NOVONIX LIMITED's current ratio of 1.07 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 16/100, which could limit financial flexibility.
While NOVONIX LIMITED generated -$42.2M in operating cash flow, capex of $60.2M consumed most of it, leaving -$102.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
NOVONIX LIMITED generates a -57.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -54.4% the prior year.
NOVONIX LIMITED passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, NOVONIX LIMITED generates $0.46 in operating cash flow (-$42.2M OCF vs -$92.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
NOVONIX LIMITED generated $5.6M in revenue in fiscal year 2025. This represents a decrease of 4.1% from the prior year.
NOVONIX LIMITED reported -$92.7M in net income in fiscal year 2025. This represents a decrease of 23.9% from the prior year.
Cash & Balance Sheet
NOVONIX LIMITED generated -$102.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 45.6% from the prior year.
NOVONIX LIMITED held $79.9M in cash against $5.9M in long-term debt as of fiscal year 2025.
NOVONIX LIMITED had 840M shares outstanding in fiscal year 2025. This represents an increase of 71.9% from the prior year.
Margins & Returns
NOVONIX LIMITED's net profit margin was -1650.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 372.7 percentage points from the prior year.
NOVONIX LIMITED's ROE was -57.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.0 percentage points from the prior year.
Capital Allocation
NOVONIX LIMITED invested $60.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 101.4% from the prior year.
NVX Income Statement
| Metric | Q4'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NVX Balance Sheet
| Metric | Q4'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $282.9M+25.1% | $226.1M-6.1% | $240.8M-8.5% | $263.3M-6.2% | $280.9M+1.3% | $277.4M-8.4% | $303.0M+98.9% | $152.3M |
| Current Assets | $89.2M+55.6% | $57.3M-1.0% | $57.9M-35.1% | $89.2M-17.9% | $108.6M-6.5% | $116.1M-28.4% | $162.2M+49.9% | $108.2M |
| Cash & Equivalents | $79.9M+87.7% | $42.6M-9.7% | $47.1M-40.1% | $78.7M-20.6% | $99.1M0.0% | $99.0M-30.6% | $142.7M+39.1% | $102.6M |
| Inventory | $2.2M+57.8% | $1.4M-32.2% | $2.0M+2.0% | $2.0M-22.0% | $2.6M-19.0% | $3.2M+69.1% | $1.9M-10.3% | $2.1M |
| Accounts Receivable | $2.1M-74.1% | $8.2M+223.7% | $2.5M-29.3% | $3.6M+53.3% | $2.3M-18.3% | $2.8M+16.1% | $2.5M+50.1% | $1.6M |
| Goodwill | $12.0M0.0% | $12.0M0.0% | $12.0M0.0% | $12.0M0.0% | $12.0M0.0% | $12.0M0.0% | $12.0M0.0% | $12.0M |
| Total Liabilities | $121.2M+37.0% | $88.5M+6.9% | $82.8M+4.2% | $79.4M+0.6% | $78.9M+53.7% | $51.4M-0.9% | $51.8M+274.1% | $13.9M |
| Current Liabilities | $83.6M+80.7% | $46.2M+391.7% | $9.4M-74.8% | $37.3M+499.0% | $6.2M-26.5% | $8.5M+7.3% | $7.9M+96.3% | $4.0M |
| Long-Term Debt | $5.9M-8.9% | $6.5M-3.9% | $6.8M+50.7% | $4.5M-3.4% | $4.6M-3.9% | $4.8M-3.6% | $5.0M-6.3% | $5.3M |
| Total Equity | $161.7M+17.5% | $137.6M-13.0% | $158.1M-14.1% | $183.9M-8.9% | $202.0M-10.7% | $226.1M-10.0% | $251.1M+81.4% | $138.4M |
| Retained Earnings | -$352.4M-35.7% | -$259.7M-21.6% | -$213.6M-15.5% | -$184.8M-10.9% | -$166.7M-20.3% | -$138.6M-25.2% | -$110.7M-88.1% | -$58.9M |
NVX Cash Flow Statement
| Metric | Q4'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
NVX Financial Ratios
| Metric | Q4'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q2'21 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 1.07-0.2 | 1.24-4.9 | 6.15+3.8 | 2.39-15.1 | 17.45+3.7 | 13.72-6.8 | 20.56-6.4 | 26.92 |
| Debt-to-Equity | 0.04-0.0 | 0.050.0 | 0.04+0.0 | 0.020.0 | 0.020.0 | 0.020.0 | 0.02-0.0 | 0.04 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is NOVONIX LIMITED's annual revenue?
NOVONIX LIMITED (NVX) reported $5.6M in total revenue for fiscal year 2025. This represents a -4.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is NOVONIX LIMITED's revenue growing?
NOVONIX LIMITED (NVX) revenue declined by 4.1% year-over-year, from $5.9M to $5.6M in fiscal year 2025.
Is NOVONIX LIMITED profitable?
No, NOVONIX LIMITED (NVX) reported a net income of -$92.7M in fiscal year 2025, with a net profit margin of -1650.8%.
How much debt does NOVONIX LIMITED have?
As of fiscal year 2025, NOVONIX LIMITED (NVX) had $79.9M in cash and equivalents against $5.9M in long-term debt.
What is NOVONIX LIMITED's net profit margin?
NOVONIX LIMITED (NVX) had a net profit margin of -1650.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is NOVONIX LIMITED's return on equity (ROE)?
NOVONIX LIMITED (NVX) has a return on equity of -57.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is NOVONIX LIMITED's free cash flow?
NOVONIX LIMITED (NVX) generated -$102.4M in free cash flow during fiscal year 2025. This represents a -45.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is NOVONIX LIMITED's operating cash flow?
NOVONIX LIMITED (NVX) generated -$42.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are NOVONIX LIMITED's total assets?
NOVONIX LIMITED (NVX) had $282.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are NOVONIX LIMITED's capital expenditures?
NOVONIX LIMITED (NVX) invested $60.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is NOVONIX LIMITED's current ratio?
NOVONIX LIMITED (NVX) had a current ratio of 1.07 as of fiscal year 2025, which is considered adequate.
What is NOVONIX LIMITED's debt-to-equity ratio?
NOVONIX LIMITED (NVX) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is NOVONIX LIMITED's return on assets (ROA)?
NOVONIX LIMITED (NVX) had a return on assets of -32.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is NOVONIX LIMITED's cash runway?
Based on fiscal year 2025 data, NOVONIX LIMITED (NVX) had $79.9M in cash against an annual operating cash burn of $42.2M. This gives an estimated cash runway of approximately 23 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is NOVONIX LIMITED's Piotroski F-Score?
NOVONIX LIMITED (NVX) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are NOVONIX LIMITED's earnings high quality?
NOVONIX LIMITED (NVX) has an earnings quality ratio of 0.46x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is NOVONIX LIMITED?
NOVONIX LIMITED (NVX) scores 29 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.